An antibody or antibody fragment directed against the CD28 receptor which blocks the interaction between B7-1 or B7-2 and CD28. Methods for blocking activation via CD28, including CD28-dependent lymphocyte activation.
Web www.patentalert.com
< Hydrophobically modified cationic polymers
< Antimicrobial compounds
> Anti-EGFR antibodies
> Cysteine engineered anti-MUC16 antibodies and antibody drug conjugates
HOME | NEW USER | LOGIN | SUBSCRIPTIONS | SEARCH | GUESTBOOK | CONTACT